Batisse-Lignier, M <br/><br/>
P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.  [electronic resource] 

 -  Oncogene  08 2017 
 - 4445-4456 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2017.54  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenocortical Carcinoma--pathology<br/>Animals<br/>Antigens, Polyomavirus Transforming--genetics<br/>Humans<br/>Mechanistic Target of Rapamycin Complex 1<br/>Mice<br/>Mice, Transgenic<br/>Multiprotein Complexes--physiology<br/>Neoplasm Metastasis<br/>Retinoblastoma Protein--antagonists & inhibitors<br/>Sirolimus--pharmacology<br/>TOR Serine-Threonine Kinases--physiology<br/>Tumor Suppressor Protein p53--antagonists & inhibitors<br/>Wnt Signaling Pathway--physiology<br/>beta Catenin--physiology